Kirenal Citraid A™

[Petty Patent no. 11133]  

Sales and Inquiries:

* A Nikkiso Medical Product:

Nikkiso Medical (Thailand) Co., Ltd.

689 Onnuch Road, Suanluang, Bangkok 10510, Thailand

Tel: (66)2-716-2894 |

Mobile: (66)86-899-9300 |

Kirenal Citraid™ is Piraab Medical’s latest innovation: The premium quality superior performing Citrate based hemodialysis acid concentrate.
Citrate, a well-known antioxidant and anticoagulant, has novel properties including short half-life and systemic release by the human body benefitting dialysis patients with reduced inflammation, lower risks of bleeding, cardiovascular diseases and hypotension, and increased energy levels.

In addition, operators and professionals will now have higher quality better performing dialysis concentrates. Citrate-infused concentrate reduces clotting rate of dialyzer and lower use of heparin. Furthermore, it is a safe biocompatible alternative to conventional dialysis concentrate.

Benefits of citrate dialysis concentrates:
  • Reduce risk of Hypotension

  • Reduce use of Heparin by 30 – 50 %

  • Reduce risk of bleeding

  • Reduce clotting of dialyzer

Screen Shot 2561-04-06 at 1.43.49 PM


Our formulas:

Screen Shot 2561-04-06 at 1.40.02 PM

For more information: CONTACT US